Glioma Clinical Trials in Rochester

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1423 more
2022-04-06
Apr 6, 2022
N
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
Recruiting
  • 1p/19q Co-deletion
  • +8 more
  • IMRT (Intensity-Modulated Radiation Therapy)
  • +2 more
  • Birmingham, Alabama
  • +26 more
2022-04-04
Apr 4, 2022
N
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Active, not recruiting
  • Glioma
  • +49 more
  • Duarte, California
  • +11 more
2022-03-01
Mar 1, 2022
C
Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Available
  • Glioma
  • H3 K27M
  • San Diego, California
  • +17 more
2022-03-01
Mar 1, 2022
W
INCMGA00012 and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Recruiting
  • Glioma
  • Glioblastoma
  • Phoenix, Arizona
  • +3 more
2022-02-16
Feb 16, 2022
E
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Recruiting
  • Cholangiocarcinoma
  • +3 more
  • Phoenix, Arizona
  • +33 more
2022-02-15
Feb 15, 2022
W
rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide
Recruiting
  • Glioma
  • Rochester, Minnesota
  • +1 more
2021-11-19
Nov 19, 2021
U
Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
Recruiting
  • Glioma
  • Early START visit using checklist over telephone or zoom
  • Rochester, New York
    University of Rochester
2021-11-09
Nov 9, 2021
M
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
2021-08-17
Aug 17, 2021
S
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Recruiting
  • Glioma
  • +6 more
  • Hippocampal-avoidance proton therapy
  • Rochester, Minnesota
  • +1 more
2021-07-30
Jul 30, 2021
R
Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma - 2019
Terminated
Has Results
  • Glioblastoma
  • +2 more
  • La Jolla, California
  • +10 more
2021-05-12
May 12, 2021
M
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
Active, not recruiting
  • Glioma
  • Fluorine F 18 Fluorodopa
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2021-04-08
Apr 8, 2021
M
Gliogene: Brain Tumor Linkage Study
Active, not recruiting
  • Brain Tumor
  • Glioma
  • Questionnaire
  • San Francisco, California
  • +14 more
2020-12-29
Dec 29, 2020
P
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin - 2020
Terminated
  • Pleural Mesothelioma Malignant Advanced
  • +6 more
  • ADI-PEG 20
  • Rochester, Minnesota
  • +3 more
2020-09-24
Sep 24, 2020
D
VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - 2019
Terminated
  • Glioblastoma Multiforme
  • +4 more
  • VAL-083, Dianhydrogalactitol
  • +3 more
  • Los Angeles, California
  • +4 more
2019-11-12
Nov 12, 2019
D
Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma - 2016
Completed
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • San Francisco, California
  • +4 more
2017-01-19
Jan 19, 2017
N
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
Unknown status
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
2016-10-12
Oct 12, 2016